The global eye drops and lubricants market generated $15,587 million in 2017 and is projected to reach $22,625 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025.
Eye drops and lubricants are used to relieve people suffering from various eye problems, such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Eye infections such as conjunctivitis and bacterial keratitis are chronic infections treated by using antibiotics therapy. Furthermore, eye and vision problems also occur due to imbalance in hormone levels, as hormones regulate important body functions and fluctuation in them can affect the eyes and vision. The discovery of advanced prospect molecules and novel combination therapies is expected to boost the growth of the eye drops and lubricants market in near future.
Rise in prevalence of ophthalmic disorders worldwide, change in the demographics across the globe, and focus on drug discovery and development for the treatment of eye disorder and diseases are the factors that drive the growth of the global eye drops and lubricants market. However, longer timelines required for the approval of eye drops and lubricants and risk of associated side effects hamper the market growth. On the contrary, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma globally are anticipated to offer lucrative opportunities for market expansion.
The global eye drops market is segmented based on type, application, and region. By type, the market is categorized into antibiotics, hormones, artificial tears, and others. Based on application, the market is divided into eye diseases, eye care, and others. The eye diseases segment is further classified into dry eye, glaucoma, conjunctivitis, refractive errors, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
o Hormones
o Artificial Tears
o Others
Dry Eye
Glaucoma
Conjunctivitis
Refractive Errors
Others
o Eye Care
o Others
KEY MARKET PLAYERS
The other players in the value chain include (profiles not included in the report):
Eye drops and lubricants are used to relieve people suffering from various eye problems, such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Eye infections such as conjunctivitis and bacterial keratitis are chronic infections treated by using antibiotics therapy. Furthermore, eye and vision problems also occur due to imbalance in hormone levels, as hormones regulate important body functions and fluctuation in them can affect the eyes and vision. The discovery of advanced prospect molecules and novel combination therapies is expected to boost the growth of the eye drops and lubricants market in near future.
Rise in prevalence of ophthalmic disorders worldwide, change in the demographics across the globe, and focus on drug discovery and development for the treatment of eye disorder and diseases are the factors that drive the growth of the global eye drops and lubricants market. However, longer timelines required for the approval of eye drops and lubricants and risk of associated side effects hamper the market growth. On the contrary, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma globally are anticipated to offer lucrative opportunities for market expansion.
The global eye drops market is segmented based on type, application, and region. By type, the market is categorized into antibiotics, hormones, artificial tears, and others. Based on application, the market is divided into eye diseases, eye care, and others. The eye diseases segment is further classified into dry eye, glaucoma, conjunctivitis, refractive errors, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global eye drops and lubricants market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
- By Type
o Hormones
o Artificial Tears
o Others
- By Application
Dry Eye
Glaucoma
Conjunctivitis
Refractive Errors
Others
o Eye Care
o Others
- By Region
- U.S.
- Canada
- Mexico
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Akorn Consumer Health (TheraTears)
- Allergan Plc
- Johnson & Johnson
- Novartis International AG (Alcon Inc.)
- Pfizer Inc.
- Prestige Consumer Healthcare, Inc.
- Sager Pharma Kft.
- ROHTO Pharmaceutical Co., Ltd.
- Similasan Corporation USA
- Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
The other players in the value chain include (profiles not included in the report):
- Jawa Pharmaceuticals Pvt. Ltd.
- Maya Biotech
- Neiss Labs Ltd.
- Hanuchem Laboratories
- Oculent Healthcare
Table of Contents
Chapter: 1: INTRODUCTION
Chapter: 2: EXECUTIVE SUMMARY
Chapter: 3: MARKET OVERVIEW
Chapter: 4: EYE DROPS AND LUBRICANTS MARKET, BY TYPE
Chapter: 5: GLOBAL EYE-DROP AND LUBRICANTS MARKET BY APPLICATION
Chapter: 6: EYE DROPS AND LUBRICANT MARKET, BY REGION
Chapter: 7: COMPANY PROFILES
Executive Summary
According to this report titled 'Eye Drops and Lubricants Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025', the global eye drops and lubricants market size is $15,587 million in 2017 and is projected to reach $22,625 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025. The artificial tears segment accounted around one-third of the total eye drops and lubricants market share in 2017.Eye drops and lubricants are used to relieve people suffering from various eye problems such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Eye infections such as conjunctivitis and bacterial keratitis are chronic infections treated by using antibiotics therapy. Furthermore, eye and vision problems also occur due to imbalance in hormone levels, as hormones regulate important body functions and fluctuation in them can affect the eyes and vision. The discovery of advanced prospect molecules and novel combination therapies is expected to boost the growth of the market in the share in the near future.
The eye drops and lubricants market is expected to exhibit significant growth during the forecast period due to rise in prevalence of ophthalmic disorders worldwide, change in the demographics across the globe, and focus on drug discovery and development for the treatment of eye disorder and diseases. However, longer timelines required for the approval of eye drops and lubricants and risk of associated side effects hamper the market growth.Conversely, increase in investment by market players in the emerging economies is expected to offer remunerative opportunities for market players.
Based on type, the eye drops and lubricants market is segmented into antibiotics, hormones, artificial tears, and others. The artificial tear segment accounted for the highest revenue in 2017 and is expected to continue this trend throughout the forecast period, owing to the rise in demand for the product, due to surge in number of dry eye syndrome across the world. Furthermore, easy availability and accessibility of lubricating eye drops even without a prescription further fuels the market growth.
Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the rapid development in healthcare infrastructure, rise in incidence of ophthalmic disorders, and increase in healthcare initiatives by its government. However, North America accounted for the highest market share in 2017, and is expected to maintain its dominance throughout the forecast period, owing to increase in prevalence of glaucoma, cataract, and other ophthalmic disorders.
The report provides global eye drops & lubricants market trends, analysis, and forecast with a comprehensive analysis of the key players operating in the global eye drops and lubricants industry, namely Akorn Consumer Health (TheraTears), Allergan Plc, Johnson & Johnson, Novartis International AG (Alcon Inc.), Pfizer Inc., Prestige Consumer Healthcare, Inc., Sager Pharma Kft., ROHTO Pharmaceutical Co., Ltd., Similasan Corporation USA, and Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated). The other players in the value chain include Jawa Pharmaceuticals Pvt. Ltd., Maya Biotech, Neiss Labs Ltd., Hanuchem Laboratories, Oculent Healthcare, and others.
Key Findings of the Eye Drops And LubricantsMarket:
Based on type, the hormones segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 5.6% from 2018 to 2025.
Depending on application, the eye diseases segment held the largest revenue in 2017 and is anticipated to continue this trend during the forecast period.
U.S. generated the highest revenue in the global eye drops and lubricants market industry in 2017, accounting more than one-third of the global market in 2017.
LAMEA is estimated to grow at a CAGR of 5.3% during the forecast period.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
